Novel Therapies and Diagnostic Methods (National Cancer Institute): Difference between revisions

From Beacon
No edit summary
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 4: Line 4:


[[Glossary|Click here for a Glossary of terms used in this page]]
[[Glossary|Click here for a Glossary of terms used in this page]]
=== Screening: Cancer prevention and screening ===
'''Primary purpose:''' To guide people at risk toward free screening tests, ensure early detection, and provide direct contact points for fast follow-up and treatment if abnormalities are found.
'''Contact information:''' [https://www.nvi.lt/storosios-zarnos-vezio-prevencija/ Click here to access colorectal screening], [https://www.nvi.lt/kruties-vezio-pp/ Click here to access breast screening], and [https://www.nvi.lt/prostatos-vezio-prevencija/ Click here to access prostate screening].


=== Diagnostics ===
=== Diagnostics ===
Line 278: Line 284:
| Facility || Home palliative care availability || yes ||  
| Facility || Home palliative care availability || yes ||  
|}
|}
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
<span style="display:none">hasCancerType::C00-C97: All cancer types</span>
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
<span style="display:none">hasCancerType::C50: Breast cancer</span>
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
<span style="display:none">hasCancerType::unknown</span>
<span style="display:none">isScreening</span>

Latest revision as of 16:53, 12 December 2025

forresearchers forpatients forproviders lithuaniacountry Go back to National Cancer Institute page

Click here for a Glossary of terms used in this page

Screening: Cancer prevention and screening[edit | edit source]

Primary purpose: To guide people at risk toward free screening tests, ensure early detection, and provide direct contact points for fast follow-up and treatment if abnormalities are found.

Contact information: Click here to access colorectal screening, Click here to access breast screening, and Click here to access prostate screening.

Diagnostics[edit | edit source]

Radiology
Type Name Availability Uses per year
Machine CT scanners yes
Machine MRI (specify the strength and field of the techniques) yes
Machine Mammography (please specify analogic mammography or digital) yes digital / 9580 (2022)
Machine Ultrasound yes
Machine Gamma Camera yes
Technique MRI-guided biopsy yes
Technique Ultrasound guided biopsy yes
Technique Endoscopic retrograde cholangiopancreatography (ERCP) yes
Technique EBUS-TBNA yes
Technique E/S Fine-needle biopsy yes
Technique Angiography yes
Nuclear Medicine
Type Name Availability Uses per year
Machine Pet Scan yes
Machine PET CT yes
Machine PET/MRI yes
Facility Radionuclide treatment facilities yes
Machine SPECT yes
Machine SPECT CT yes
Technique Bone scintigraphy yes 5158 (2022)
Pathology
Type Name Availability Uses per year
Facility Cytology laboratory yes 8715 tests (2022)
Facility Histopathology laboratory yes
Technique Comparative Genomic Hybridization (CGH) yes
Technique FISH (Fluorescence In Situ Hybridization) yes
Technique PCR (Polymerase Chain Reaction) yes
Technique Cytometry yes
Technique Liquid biopsy yes
Technique Immunofluorescence techniques yes
Technique Histochemistry yes
Technique Techniques for molecular pathology yes
Technique Cytogenetics yes
Pathology: Molecular Tests
Type Name Availability Uses per year
Technique PDL1 yes
Technique PI3KCA yes 18 (2022)
Technique KRAS yes
Technique BRAF yes 106 (2022)
Technique EGFR yes 71 (2022)
Technique ALK yes
Technique ROS yes
Technique HER2 status yes
Technique COMPREHENSIVE MOLECULAR PANELS yes
Others
Type Name Availability Uses per year
Technique Bronchoscopy yes
Technique Colposcopy yes
Technique Colonoscopy yes >1000 (yearly)
Technique Hysteroscopy yes

Treatment[edit | edit source]

Surgical Oncology
Type Name Availability Uses per year
Specialist Breast surgery yes 678 (2022)
Specialist Urological surgery yes 428 (2022)
Specialist Thoracic surgery yes
Specialist Digestive surgery yes 585 (2022)
Specialist Gynaecological surgery yes 362 (2022)
Specialist Head and neck surgery yes 99 (2022)
Specialist Soft tissue surgery yes
Specialist Oncoplastic surgery yes
Specialist Sarcoma surgery yes
Technique Video-assisted thoracoscopy yes
Radiotherapy
Type Name Availability Uses per year
Facility Total MegaVoltage units 4 +51000 (yearly)
Machine Linear accelerators yes
Machine Linear accelerators with IMRT/VMAT yes 31125 (2022)
Machine Linear accelerators with IGRT yes
Machine Linear accelerators with SBRT/SRS yes
Machine Cobalt Units yes
Machine Brachytherapy unit yes 720
Technique Intraperitoneal chemo-hyperthermia (HIPEC) yes
Technique Stereotactic radiotherapy yes
Technique Locoregional chemotherapy yes
Technique Chemoembolization yes
Technique Thermal ablation (with radiofrequency or microwave) yes both
Technique Total Body Irradiation (TBI) yes
Technique 3D conformal radiotherapy yes
Technique Radiosurgery yes
Technique CT planning yes
Technique IMRT radiotherapy planning system yes 1910 (2022)
Technique Magnetic resonance for radiotherapy treatment planning yes
Technique PET CT treatment planning yes
Hemato-Oncology / Bone Marrow Transplants
Type Name Availability Uses per year
Facility Transfusion Unit yes
Facility Cellular therapy unit with GMP (Good Manufacturing Practice) yes
Technique Quality Vigilance System yes
Technique Allogenic stem cell transplants yes
Technique Autologous bone marrow transplants yes
Technique Autologous stem cell transplants yes
Specialists
Type Name Availability Uses per year
Specialist Physician with a specialisation in palliative care yes
Specialist Medical oncologist yes
Specialist Nurse with a specialisation/certification in palliative care yes
Specialist Physician specialised in pain treatment yes
Specialist Lung physician yes
Specialist Radiotherapist 16
Specialist Psychologist or Psychotherapist 3
Specialist Psychiatrist 1
Specialist Social worker 1
Specialist Physiotherapist yes
Specialist Dietitian 1
Others
Type Name Availability Uses per year
Facility 24-hour Oncological Emergency Department yes 1519 receptions and emergency services (2022)
Technique Interventional Endoscopy yes
Technique Rigid Bronchoscopy yes
Technique Nephrostomy yes
Facility Clinical Trial Center yes
Facility Phase 1 Clinical Trial Unit yes
Technique Intraperitoneal Chemotherapy with Pressurized Air Flow (PIPAC) yes

Prevention[edit | edit source]

Screening and Others
Type Name Availibility Uses per year
Facility Lung cancer screening program yes
Facility Breast cancer screening program yes
Facility Cervical cancer screening program yes
Facility Colorectal cancer screening program yes

Quality of Life[edit | edit source]

Quality of Life
Type Name Availibility Uses per year
Facility Supportive care unit yes

Palliative Care[edit | edit source]

Palliative Care
Type Name Availibility Uses per year
Facility Home palliative care availability yes

hasCancerType::C00-D48: All neoplasms hasCancerType::C00-C97: All cancer types hasCancerType::C00-C14: Mouth/throat cancers hasCancerType::C15-C26: Digestive system cancers hasCancerType::C30-C39: Lung/chest cancers hasCancerType::C40-C41: Bone cancers hasCancerType::C43-C44: Skin cancers/melanoma hasCancerType::C45-C49: Soft tissue cancer hasCancerType::C50: Breast cancer hasCancerType::C51-C58: Female genitalia cancers hasCancerType::C60-C63: Male genitalia cancer hasCancerType::C64-C68: Urinary system cancers hasCancerType::C69-C72: Eye and brain cancer hasCancerType::C73-C75: Thyroid and other gland cancers hasCancerType::C76-C80: Cancers of unknown or unspecified areas hasCancerType::C81-C96: Cancers of the blood and immune system hasCancerType::C97-C97: Cancers in multiple locations from the start hasCancerType::D00-D09: Early-stage cancers not yet spread hasCancerType::D10-D36: Benign tumour hasCancerType::D37-D48: Growths of uncertain nature hasCancerType::unknown isScreening